Le Lézard
Classified in: Health
Subject: MAV

National Access Cannabis Establishes Landmark Limited Partnership Agreements with 3 First Nations in Manitoba


NAC and participating First Nations to host signing ceremony Friday morning

OTTAWA, Dec. 15, 2017 /CNW/ - National Access Cannabis Corp. ("NAC" or the "Company") (TSX VENTURE: NAC), Canada's best practices leader in delivering secure, safe, and responsible access to legal medical cannabis today announced that the Company has entered into Limited Partnership Agreements (the "Agreements") with three Manitoba Indigenous First Nations. Under the terms of the Agreements, each of the Opaskwayak Cree Nation, Long Plain First Nation, and Peguis First Nation have partnered with NAC to establish a retail recreational cannabis distribution network in Manitoba, when legally permissible to do so.

National Access Cannabis (NAC) (CNW Group/National Access Cannabis (NAC))

Through the Agreements, NAC, in partnership with each of the three First Nations, intends to build out and operate a network of recreational cannabis stores located on the respective First Nation's owned land in Manitoba, when legally permitted to do so and in response to the Manitoba RFP. It is intended that the locations will be staffed by First Nation's members and trained using NAC's proprietary model to ensure safe and secure distribution of legal cannabis.

"These unique partnerships present a fantastic economic opportunity for the participating First Nations," said Mark Goliger, Chief Executive Officer of National Access Cannabis. "With the benefit of NAC's established operating model, First Nation's will supply legal cannabis, leveraging our deep knowledge of safety, security and harm reduction through a network of First Nation owned stores in Manitoba. This partnership not only supports Manitoba's Indigenous First Nations, but also the province in meeting its obligations to provide Manitoban's access to safe and legal cannabis. We are working towards more of these win-win partnerships here in Manitoba and elsewhere in other provinces."

NAC and the participating First Nations will host a signing ceremony Friday, December 15, 2017 at 10:00 a.m. Central Time at NAC's Winnipeg medical clinic. All interested media parties are invited to join.

CEREMONY DETAILS




DATE:

Friday, December 15th, 2017

TIME:

10:00 a.m. Central Time (11:00 a.m. Eastern Time)

LOCATION:

NAC Winnipeg


379 Broadway #101


Winnipeg, MB


R3C 0T9



About National Access Cannabis

National Access Cannabis is Canada's best practices leader in delivering secure, safe, and responsible access to legal medical cannabis. NAC enables patients to gain knowledge and the legal medical documentation required to navigate Canada's disparate network of authorized Licensed Producers of Cannabis. Through its Canada-wide network of care centres, NAC has partnered with health professionals to improve the quality of life of its local members and provide services designed to inform, educate and supply expert advice.

nationalaccesscannabis.com

National Access Cannabis Corp. is listed on the TSX Venture Exchange under the symbol (TSXV: NAC).

Cautionary Statements

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the entering into of the limited partnership agreements and future developments including the establishment of a recreational cannabis distribution network in Manitoba and the structure. Although the Corporation believes in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Corporation can give no assurance that they will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those that are currently contemplated by these statements depending on, among other things, the risks and failure to obtain distribution and operating licenses from applicable regulatory authorities. The Corporation undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Corporation, its securities, or its financial or operating results (as applicable). The statements in this news release are made as of the date of this release.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE National Access Cannabis (NAC)


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: